These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26017421)

  • 1. Bacterial arms race revs up.
    Reardon S
    Nature; 2015 May; 521(7553):402-3. PubMed ID: 26017421
    [No Abstract]   [Full Text] [Related]  

  • 2. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified viruses deliver death to antibiotic-resistant bacteria.
    Reardon S
    Nature; 2017 Jun; 546(7660):586-587. PubMed ID: 28661508
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial resistance to cationic antimicrobial peptides.
    Anaya-López JL; López-Meza JE; Ochoa-Zarzosa A
    Crit Rev Microbiol; 2013 May; 39(2):180-95. PubMed ID: 22799636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predatory bacteria: a new therapeutic approach for a post-antibiotic era.
    Shatzkes K; Connell ND; Kadouri DE
    Future Microbiol; 2017 May; 12():469-472. PubMed ID: 28481158
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.
    Ghosh C; Sarkar P; Issa R; Haldar J
    Trends Microbiol; 2019 Apr; 27(4):323-338. PubMed ID: 30683453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota transplantation and/or CRISPR/Cas in the battle against antimicrobial resistance.
    Vila J
    Clin Microbiol Infect; 2018 Jul; 24(7):684-686. PubMed ID: 29653191
    [No Abstract]   [Full Text] [Related]  

  • 9. Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria.
    Li W; Tailhades J; O'Brien-Simpson NM; Separovic F; Otvos L; Hossain MA; Wade JD
    Amino Acids; 2014 Oct; 46(10):2287-94. PubMed ID: 25141976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bacteriophage journey at the European Medicines Agency.
    Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C
    FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial resistance to antimicrobial peptides.
    Sahl HG; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3019-20. PubMed ID: 26342677
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles.
    Rajchakit U; Sarojini V
    Bioconjug Chem; 2017 Nov; 28(11):2673-2686. PubMed ID: 28892365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do antimicrobial peptides and antimicrobial-peptide resistance play important roles during bacterial infection?
    Cheung GY; Otto M
    Future Microbiol; 2018 Aug; 13(10):1073-1075. PubMed ID: 30113237
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
    Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
    Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides: their physicochemical properties and therapeutic application.
    Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
    Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting bacterial infections-future treatment options.
    Fernebro J
    Drug Resist Updat; 2011 Apr; 14(2):125-39. PubMed ID: 21367651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.
    Hwang IY; Koh E; Kim HR; Yew WS; Chang MW
    Drug Resist Updat; 2016 Jul; 27():59-71. PubMed ID: 27449598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are cationic antimicrobial peptides also 'double-edged swords'?
    Ginsburg I; Koren E
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):453-62. PubMed ID: 18662113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and overcoming antibiotic resistance.
    Richardson LA
    PLoS Biol; 2017 Aug; 15(8):e2003775. PubMed ID: 28832581
    [No Abstract]   [Full Text] [Related]  

  • 20. Surviving innate immunity.
    Nizet V; Gallo RL
    Trends Microbiol; 2002 Aug; 10(8):358-9. PubMed ID: 12160630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.